These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 31779293)
41. An interdisciplinary review of digital technologies to facilitate anti-corruption, transparency and accountability in medicines procurement. Mackey TK; Cuomo RE Glob Health Action; 2020; 13(sup1):1695241. PubMed ID: 32194014 [No Abstract] [Full Text] [Related]
42. Why the MDGs need good governance in pharmaceutical systems to promote global health. Kohler JC; Mackey TK; Ovtcharenko N BMC Public Health; 2014 Jan; 14():63. PubMed ID: 24447600 [TBL] [Abstract][Full Text] [Related]
43. Targeting anticorruption interventions at the front line: developmental governance in health systems. Hutchinson E; Naher N; Roy P; McKee M; Mayhew SH; Ahmed SM; Balabanova D BMJ Glob Health; 2020 Dec; 5(12):. PubMed ID: 33272939 [TBL] [Abstract][Full Text] [Related]
44. The procurement of the UN sustainable development goals and the American national policy agenda of nurses. Miyamoto S; Cook E Nurs Outlook; 2019; 67(6):658-663. PubMed ID: 31653341 [TBL] [Abstract][Full Text] [Related]
45. Gastrointestinal cancer prevention policies in Iran: A policy analysis of agenda-setting using Kingdon's multiple streams. Kabiri N; Khodayari-Zarnaq R; Khoshbaten M; Arab-Zozani M; Janati A J Cancer Policy; 2021 Mar; 27():100265. PubMed ID: 35559940 [TBL] [Abstract][Full Text] [Related]
46. From the Myth of Level Playing Fields to the Reality of a Finite Planet: Comment on "A Global Social Support System: What the International Community Could Learn From the United States' National Basketball Association's Scheme for Redistribution of New Talent". Labonté R Int J Health Policy Manag; 2015 Nov; 5(2):137-9. PubMed ID: 26927404 [TBL] [Abstract][Full Text] [Related]
47. The disease of corruption: views on how to fight corruption to advance 21 Mackey TK; Kohler JC; Savedoff WD; Vogl F; Lewis M; Sale J; Michaud J; Vian T BMC Med; 2016 Sep; 14(1):149. PubMed ID: 27680102 [TBL] [Abstract][Full Text] [Related]
48. Can Strategic Health Purchasing Reduce Inefficiency and Corruption in the Health Sector? The Case of Nigeria. Onwujekwe O; Agwu P Health Syst Reform; 2022 Mar; 8(2):e2057836. PubMed ID: 36562733 [TBL] [Abstract][Full Text] [Related]
49. Promoting anti-corruption, transparency and accountability in the recruitment and promotion of health workers to safeguard health outcomes. Kirya MT Glob Health Action; 2020; 13(sup1):1701326. PubMed ID: 32194012 [No Abstract] [Full Text] [Related]
50. Human Rights Discourse in the Sustainable Development Agenda Avoids Obligations and Entitlements Comment on "Rights Language in the Sustainable Development Agenda: Has Right to Health Discourse and Norms Shaped Health Goals?". Williams C; Blaiklock A Int J Health Policy Manag; 2016 Mar; 5(6):387-90. PubMed ID: 27285518 [TBL] [Abstract][Full Text] [Related]
51. "It Keeps Us from Putting Drugs in Pockets": How a Public-Private Partnership for Hospital Management May Help Curb Corruption. Vian T; Mcintosh N; Grabowski A Perm J; 2017; 21():16-113. PubMed ID: 28746025 [TBL] [Abstract][Full Text] [Related]
52. We Need to Measure and Address Corruption and Poor Governance in Health Systems Comment on "We Need to Talk About Corruption in Health Systems". Lewis M Int J Health Policy Manag; 2019 Oct; 8(10):616-619. PubMed ID: 31657190 [TBL] [Abstract][Full Text] [Related]
53. Not Up for Discussion: Applying Lukes' Power Model to the Study of Health System Corruption Comment on "We Need to Talk About Corruption in Health Systems". Reynolds L Int J Health Policy Manag; 2019 Dec; 8(12):723-726. PubMed ID: 31779300 [TBL] [Abstract][Full Text] [Related]
54. Monitoring the sustainable development goals through human rights accountability reviews. Bueno de Mesquita J; Thomas R; Gauter C; Havkwist A; Hoddy R; Larasati A; Gjerdset IL; Perrone G; Sadiq T; Smith RA Bull World Health Organ; 2018 Sep; 96(9):627-633. PubMed ID: 30262944 [TBL] [Abstract][Full Text] [Related]
55. Agenda-setting in policies related to high-risk sexual behaviours, stimulants, and alcohol abuse in Iranian adolescents. Mirzaei S; Mehrolhassani MH; Yazdi-Feyzabadi V; Haghdoost A; Oroomiei N Health Res Policy Syst; 2023 Oct; 21(1):104. PubMed ID: 37814264 [TBL] [Abstract][Full Text] [Related]
56. Vitamin D deficiency prevention policies in Iran: a retrospective policy analysis. Aghapour B; Kheirouri S; Alizadeh M; Khodayari-Zarnaq R Front Nutr; 2023; 10():1249402. PubMed ID: 37680901 [TBL] [Abstract][Full Text] [Related]
57. Towards a global monitoring system for implementing the Rio Political Declaration on Social Determinants of Health: developing a core set of indicators for government action on the social determinants of health to improve health equity. Working Group for Monitoring Action on the Social Determinants of Health Int J Equity Health; 2018 Sep; 17(1):136. PubMed ID: 30185200 [TBL] [Abstract][Full Text] [Related]
58. Disability and the post-2015 development agenda. Tardi R; Njelesani J Disabil Rehabil; 2015; 37(16):1496-500. PubMed ID: 25350660 [TBL] [Abstract][Full Text] [Related]
59. Policy responses to COVID-19 present a window of opportunity for a paradigm shift in global health policy: An application of the Multiple Streams Framework as a heuristic. Amri MM; Logan D Glob Public Health; 2021; 16(8-9):1187-1197. PubMed ID: 34044747 [TBL] [Abstract][Full Text] [Related]
60. Neurosurgery and Sustainable Development Goals. Barthélemy EJ; Park KB; Johnson W World Neurosurg; 2018 Dec; 120():143-152. PubMed ID: 30144610 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]